Information  X 
Enter a valid email address

Ideagen PLC (IDEA)

  Print   

Wednesday 03 February, 2021

Ideagen PLC

Extension to 2018 LTIP Awards

RNS Number : 8631N
Ideagen PLC
03 February 2021
 

Ideagen PLC

("Ideagen"," the "Company" or the "Group'')

Extension to 2018 Long Term Incentive Plan Awards

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, announces the award of 250,000 share options over the Company's ordinary shares of 1 penny each ("Ordinary Shares") to two of the Group's senior executives under an extension to the Company's 2018 Long Term Incentive Plan (the "2018 LTIP").

The awards reward and reflect their contributions since joining the Group in May 2019. The awards could not for practical reasons have been made sooner.

The principles underpinning the awards are the same as those of the 2018 LTIP award made to Ben Dorks, Chief Executive Officer (announced on 23 October 2018) and to other directors and executives of the Company (announced on 29 March 2019) insofar that they will become eligible to vest on the Company's share price reaching 259 pence over 30 consecutive business days but not before the third anniversary of the grant date. Thereafter, any Ordinary Shares issued in respect of the exercise of any of these options cannot be sold until the fourth anniversary of the grant date except to meet the taxation costs arising on the exercise of those options. They are also subject to continued service throughout as well as the aforementioned share price targets. These options each have an exercise price of 1 penny per Ordinary Share. 

Following the award of these options and the surrender of 250,000 options by a departing employee, there are now 3,429,500 options over Ordinary Shares in issue, representing 1.36% of the issued share capital of the Company.

Enquiries:

Ideagen plc

01629 699 100

Ben Dorks, Chief Executive Officer


Emma Hayes, Chief Financial Officer

 




finnCap Limited

020 7220 0500

Henrik Persson/James Thompson (Nomad)


Alice Lane (ECM)

 


Canaccord Genuity

020 7523 8000

Simon Bridges


Richard Andrews


About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

A global supplier of regulatory and compliance solutions, Ideagen provides a common software platform and an integrated risk-based approach to meet multi-industry standards, enabling compliance with relevant laws, policies, and regulations.

The Group provides software and services to organisations operating within highly regulated industries such as life sciences, healthcare, banking and finance, insurance, aviation, and aerospace and defence, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

Currently, more than 5,700 organisations use Ideagen's products including eight of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 250 hospitals across the UK and US amongst its client base. For further information please visit www.ideagen.com .

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Arun Varma

2. 

Reason for the Notification

a)

Position/status

Chief Marketing Officer and PDMR

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Issue of options over Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1 penny

 250,000

d)

Aggregated information:

· Aggregated volume

· Price

N/A

e)

Date of the transaction

02 February 2021

f)

Place of the transaction

Off market transaction

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Geoff Neil

2. 

Reason for the Notification

a)

Position/status

Chief Development Officer and PDMR

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Issue of options over Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1 penny

 250,000

d)

Aggregated information:

· Aggregated volume

· Price

N/A

e)

Date of the transaction

02 February 2021

f)

Place of the transaction

Off market transaction

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHTJMLTMTJMMJB

a d v e r t i s e m e n t